BioHealth News
PQE Group Receives Certifications from ISO/IEC 27001 and A Women’s Business Enterprise
Italy, December 23, 2024. PQE Group is proud to announce its most recently-received official recognitions: ISO/IEC 27001 and A Women’s Business Enterprise (WBE) Certifications,…
Read More
Washington Mayor Bowser Launches $26 Million Fund to Drive New Venture Capital Investments to DC-Based Start-Ups
Monday, December 16, 2024 (Washington, DC) – Today, Mayor Muriel Bowser launched the DC Venture Capital Program, a new $26 million fund designed to…
Read More
United Therapeutics Announces Successful World’s First UKidney Transplant
SILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, today announced the world’s first transplant of a…
Read More
PMF: How to pitch to investors. The startup pitch framework + data room template + what only 1% entrepreneurs do + favorite deck slides
Guillermo Flor - How to pitch to investorsThe basics:1. Venture Capitalists have an investment thesis they have to follow. If your startup doesn’t fit…
Read More
Emergent BioSolutions Secures $50M BARDA Contract to Supply CYFENDUS® Anthrax Vaccine
GAITHERSBURG, Md., Dec. 16, 2024 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today announced that the Biomedical Advanced Research and Development Authority (BARDA) within the Administration for Strategic Preparedness…
Read More
WBJ: Connected DMV taps new CEO
By Ana Lucía Murillo – Staff Reporter, Washington Business Journal Dec 12, 2024 - Connected DMV has tapped a new chief executive to lead the regionally focused nonprofit.…
Read More
Liquet™ Medical Inc. Receives FDA 510(k) Clearance for the Versus™ Catheter
RICHMOND, VA, UNITED STATES, December 11, 2024 /EINPresswire.com/ -- Liquet Medical Inc., a pioneering medical device company committed to advancing patient care through innovative technologies, today…
Read More
Novavax Advances Corporate Growth Strategy Through Sanofi Partnership, Including Achievement of First $50 Million Milestone
GAITHERSBURG, Md., Dec. 13, 2024 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its Matrix-M™ adjuvant, today announced progress in Q4 2024…
Read More
Washington’s 60 Degrees Pharmaceuticals Adds Brigham and Women’s Hospital to Tafenoquine Babesiosis Trial
WASHINGTON, Dec. 11, 2024 (GLOBE NEWSWIRE) -- 60 Degrees Pharmaceuticals, Inc. (NASDAQ: SXTP; SXTPW) (60 Degrees Pharmaceuticals or the “Company”), a pharmaceutical company focused on developing…
Read More
Governor Moore Announces Maryland Soft Landing Exchange Business Incubator and Accelerator Program Now Open
ANNAPOLIS, MD – Governor Wes Moore today announced that applications are being accepted for the Maryland Soft Landing Exchange Program, which allows Maryland companies to explore international…
Read More
Emmes adds Bryan Patterson to lead as Senior Vice President of Government Business Development & Capture
Emmes®, part of Emmes Group®, a leading specialty tech and AI-enabled global contract research organization (CRO), today announced the appointment of Bryan Patterson to the newly…
Read More
Novavax Initiates Phase 3 Trial for COVID-19-Influenza Combination and Stand-Alone Influenza
GAITHERSBURG, Md., Dec. 10, 2024 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its Matrix-M™ adjuvant, today announced that the first participants…
Read More
Theradaptive Obtains FDA IDE Approval to Study OsteoAdapt™ SP in Additional Spinal Fusion Indications
FREDERICK, Md., Dec. 10, 2024 /PRNewswire/ -- Theradaptive, a privately held, clinical stage biologics company developing protein therapeutics for spine, orthopedics, soft tissue repair, and targeted…
Read More
BHI at TEDCO’s 10th Entrepreneur Expo: A Celebration of Maryland’s Innovation Ecosystem
On December 4th, TEDCO hosted its 10th Entrepreneur Expo in Baltimore, bringing together over 1,000 entrepreneurs, investors, and industry leaders for a day of…
Read More
NextCure Secures FDA IND Approval to Launch Phase 1 Trial of LNCB74 Antibody-Drug Conjugate for Cancer
BELTSVILLE, Md., Dec. 10, 2024 (GLOBE NEWSWIRE) -- NextCure, Inc. (Nasdaq: NXTC), a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class, and best-in-class therapies…
Read More